Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 8.70
- Piotroski Score 4.00
- Grade Buy
- Symbol (ABIO)
- Company ARCA biopharma, Inc.
- Price $28.80
- Changes Percentage (1052%)
- Change $26.3
- Day Low $2.25
- Day High $28.80
- Year High $53.88
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.
- Last Earnings N/A
- Ex-Dividend for 5/16 Dividend 08/29/2024
- Dividend Payable N/A
- Today N/A
- Next Earnings (Estimated) 10/15/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.42
- Trailing P/E Ratio -7.81
- Forward P/E Ratio -7.81
- P/E Growth -7.81
- Net Income $-5,339,000
Income Statement
Quarterly
Annual
Latest News of ABIO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Ex Real Madrid and Juventus defender Fabio Cannavaro in talks to become Deportivo head coach
Former Ballon d'Or winner Cannavaro, recently leaving Udinese, is in talks with Spanish club Deportivo for their head coach position....
By The New York Times | 2 weeks ago -
Fabio Wardley stuns Frazer Clarke with first-round KO to retain British title
Fabio Wardley secures a first-round knockout in his rematch against Frazer Clarke to defend his British heavyweight title....
By The Guardian | 1 month ago -
Adrien Rabiot completes Marseille move
Adrien Rabiot has officially signed a two-year contract with Marseille after leaving Juventus as a free agent. The French midfielder, who previously played for PSG, joins a revamped Marseille squad un...
By The New York Times | 2 months ago
